Eltacin®
Biotics
1560 Items
2019-09-19
- done All payments are SSL encrypted
- done Full Refund if you haven't received your order
- done International shipping to the USA, UK and Europe
Clinical Pharmacology
Eltacin is a combined drug that contains a mixture of essential amino acids: glycine, glutamic acid and cystine, which are metabolic regulators: they increase the intracellular concentration of glutathione and the activity of glutathione-dependent enzymes that normalize the redox processes and oxygen utilization in tissues, due to which the drug:
- shows antioxidant (reducing the content of free radicals, peroxide compounds, malonic dialdehyde) and antihypoxant (increasing the body's resistance to oxygen deficiency, enhancing the synthesis of adenosine triphosphate acid (ATP));
- increases myocardial contractility;
- increases physical performance;
- improves the quality of life of patients with chronic heart failure (increasing social adaptation, improving the psycho-emotional state);
- accelerates the recovery of performance after intense physical exertion in children.
Indications
- Chronic heart failure I-III functional class according to the NYHA classification in adults (against the background of standard therapy).
- Chronic heart failure I-II functional class according to the NYHA classification in children aged 12 to 18 years (against the background of standard therapy).
- Autonomic dysfunction syndrome in children aged 12 to 18 years.
- Prevention of chronic physical overstrain and recovery after intense physical exertion when playing sports in children aged 11 to 15 years.
Composition
1 tablet sublingual contains:
active substances: glycine 70 mg, L-glutamic acid 70 mg, L-cystine 70 mg,
excipients: methylcellulose water-soluble 7.8 mg; magnesium stearate 2.2 mg
No customer reviews for the moment.
Dosage and Administration
Eltacin take sublingual. The tablet can also be chewed and held in the mouth under the tongue until completely dissolved.
Chronic heart failure I-III functional class according to the NYHA classification in adults: 1 tablet 3 times a day sublingual, a course of treatment from 1 to 3 months depending on the severity of the disease, repeated courses are prescribed by a doctor.
Chronic heart failure of the I-II functional class according to the NYHA classification in children aged 12 to 18 years: 1 tablet 3 times a day sublingual, treatment from 1 to 3 months depending on the severity of the disease, repeated courses are prescribed by a doctor.
Autonomic dysfunction syndrome in children aged 12 to 18 years: 1 tablet 3 times a day sublingual, treatment from 1 to 3 months, depending on the severity of the disease, repeated courses are prescribed by a doctor.
Prevention of chronic physical overstrain in children aged 11 to 15 years: 1 tablet 2 times a day for 2-3 weeks.
During the recovery period after intense physical exertion during sports activities in children aged 11 to 15 years, take 1 tablet 3 times a day for 2 weeks.
Adverse reactions
Allergic reactions are possible.
Contraindications
Hypersensitivity to the drug Eltacin, children under 11 years of age (efficacy and safety have not been established).
Drug interactions
It can be taken simultaneously with inhibitors of angiotensin-converting enzyme (ACE), beta-blockers, diuretics, aldosterone antagonists, organic nitrates and blockers of "slow" calcium channels.
Pregnancy and Lactation
Clinical studies of the drug in pregnant women and during lactation has not been conducted. Not recommended for use during pregnancy and lactation.
Customers who bought this product also bought:
8 other products in the same category:
arrow_upward